Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of N-Acetyl Cystein in Preventing Contrast Induced Nephropathy: A Double Blind Double Dummy Randomized Controlled Trial

NCT01820195 is registered in ClinicalTrials.gov with Imam Khomeini Hospital as lead sponsor.

NCT NCT01820195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01820195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of N-Acetyl Cystein in Preventing Contrast Induced Nephropathy: A Double Blind Double Dummy Randomized Controlled Trial
Lead sponsor
Imam Khomeini Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
March 31, 2013
Completion date
November 30, 2014
Enrollment
549 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease stage 2, radiographic contrast agent nephropathy